How recent manufacturer savings programs may impact individual out-of-pocket spending on asthma and COPD inhalers - Peterson-KFF Health System Tracker

Summary: Breathing just got cheaper. Panel 1: Asthma & COPD inhalers capped at $35/mo. Panel 2: Some are exactly $0. Kicker: No more pharmacy panic attacks.

(Word count: 20 words)

Tags

Lung Diseases
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Disease
Asthma
Prescription Drugs
Nebulizers and Vaporizers